Loxenil IV Adverse Reactions

The table as follows provides a listing of the most serious and frequent (≥0.1%) adverse drug reactions that occurred in clinical studies that enrolled more than 2,000 adult patients who received the recommended linezolid doses for up to 28 days.
Those most commonly reported were diarrhoea (8.4%), headache (6.5%), nausea (6.3%) and vomiting (4.0%).
The most commonly reported drug-related adverse events which led to discontinuation of treatment were headache, diarrhoea, nausea and vomiting. About 3% of patients discontinued treatment because they experienced a drug-related adverse event.
Additional adverse reactions reported from post-marketing experience are included in the table with frequency category 'Not known', since the actual frequency cannot be estimated from the available data.
The following undesirable effects have been observed and reported during treatment with linezolid with the following frequencies (see Table 2): Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); Not known (cannot be estimated from the available data). (See Table 2.)

Click on icon to see table/diagram/image

Paediatric population: Safety data from clinical studies based on more than 500 paediatric patients (from birth to 17 years) do not indicate that the safety profile of linezolid for paediatric patients differs from that for adult patients.